Why are the research and testimonies of Vitamin B17 so hush-hush?
- 1 people answered
Edit Tags
Tags are used to find the best answers
You might also be interested in
treatment for tumor in the liver depends on the kind of tumor and its extent. please share your reports for a better advice.
It depends on the country. Overdiagnosis relates to the finding of a cancer that doesn’t act in a life-limiting way. Since the beginning of mammography and PSA eras we have diagnosed a lot of such disease.Mammography has not changed the percentage of women who have metastatic disease, rather it has ....
Direct breastfeeding could cut the chance of breast cancer by up to one fifth. It’s actually a “powerful strategy” to reduce the risk of cancer for you, especially the most aggressive types of disease. Scientists believe the high hormone levels required for lactation appears to affect cell growth, p....
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
எழுதியவர்:Dr. Nitika Sharma - BDS
மதிப்பிட்டவர்:Dr. Rakesh Kumar - MBBS, MS
Nidii Berwal
Vitamin B17 is not actually a vitamin. Vitamins are essential for human health. B17 is a poison also known as amygdalin as well as drugs. Amygdalin is broken down into cyanide, which is an incredibly toxic substance. There is zero reason to use it to treat cancer. There is no scientific evidence is works. It’s one of the clearest cases of snake oil medicine. This drug is a cyanogenic glycoside, a conjugate of cyanide and a sugar. They are a common type of chemical many plants produce for chemical self-defense: to keep their seeds from getting chewed up (apples, cherries, apricots, raw lima beans, bitter almonds) or seedlings eaten (sorghum) or roots eaten (cassava, processed to remove most of the cyanide in order to make tapioca). It was first experimented by former Soviet Union scientist in the 50’s of the 20th century and abandoned. The interest re-emerged in USA after Erns T. Krebs patented a method to synthesize a simplified version of the compound and started promoting it as treatment for cancer, it was utilized in many patients off-code until the FDA banned it.